September 2018

Editorial 
Pembrolizumab in patients with thymic carcinoma: a cautionary tale
Jessica A. Hellyer, Sukhmani K. Padda, Heather A. Wakelee
Mediastinum  
2018,  
2:
55  
Editorial 
Expression patterns and prognostic value of programmed death ligand-1 and programmed death 1 in thymoma and thymic carcinoma
Ikuo Sekine, Yuka Aida, Hideo Suzuki
Mediastinum  
2018,  
2:
54  
iMDT Corner 
Case presentations and recommendations from the October 2017 ITMIG tumor board: an international multidisciplinary team
Samantha Sigurdson, Edith M. Marom, Anja C. Roden, Frank C. Detterbeck, Conrad B. Falkson
Mediastinum  
2018,  
2:
53